+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "FDA Warning Letter"

How to Write Effective 483 and Warning Letter Responses - Webinar (Recorded) - Product Thumbnail Image

How to Write Effective 483 and Warning Letter Responses - Webinar (Recorded)

  • Webinar
  • March 2019
  • 90 Minutes
  • Global
6-Hour Virtual Seminar on Good Documentation and Record Keeping Best Practices (FDA & EMA) - Webinar (Recorded) - Product Thumbnail Image

6-Hour Virtual Seminar on Good Documentation and Record Keeping Best Practices (FDA & EMA) - Webinar (Recorded)

  • Webinar
  • January 2019
  • 6 Hours
  • Global
From
How to Prepare for an FDA Inspections? - Webinar (Recorded) - Product Thumbnail Image

How to Prepare for an FDA Inspections? - Webinar (Recorded)

  • Webinar
  • January 2019
  • 90 Minutes
  • Global
Meet the Tougher U.S. FDA CGMPs - Webinar (Recorded) - Product Thumbnail Image

Meet the Tougher U.S. FDA CGMPs - Webinar (Recorded)

  • Webinar
  • November 2018
  • 90 Minutes
  • United States
3hr Virtual Seminar - Validation, Verification and Transfer of Analytical Methods - Implementing Guidelines from FDA/EMA, USP and ICH - Webinar (Recorded) - Product Thumbnail Image

3hr Virtual Seminar - Validation, Verification and Transfer of Analytical Methods - Implementing Guidelines from FDA/EMA, USP and ICH - Webinar (Recorded)

  • Webinar
  • October 2018
  • 180 Minutes
  • Global
FDA's New Enforcement of 21 CFR Part 11 - Webinar (Recorded) - Product Thumbnail Image

FDA's New Enforcement of 21 CFR Part 11 - Webinar (Recorded)

  • Webinar
  • September 2018
  • 75 Minutes
  • Global
cGMPs in the Quality Control Laboratory - Webinar (Recorded) - Product Thumbnail Image

cGMPs in the Quality Control Laboratory - Webinar (Recorded)

  • Webinar
  • September 2018
  • 90 Minutes
  • Global
From
3-Hour Virtual Seminar on FDA's New Enforcement of 21 CFR Part 11 - Webinar (Recorded) - Product Thumbnail Image

3-Hour Virtual Seminar on FDA's New Enforcement of 21 CFR Part 11 - Webinar (Recorded)

  • Webinar
  • August 2018
  • 180 Minutes
  • Global
Implementation and Management of GMP Data Integrity - Webinar (Recorded) - Product Thumbnail Image

Implementation and Management of GMP Data Integrity - Webinar (Recorded)

  • Webinar
  • August 2018
  • 90 Minutes
  • Global
3-Hour Virtual Seminar on Verification vs Validation-Product, Process or Equipment and QMS Software - Webinar (Recorded) - Product Thumbnail Image

3-Hour Virtual Seminar on Verification vs Validation-Product, Process or Equipment and QMS Software - Webinar (Recorded)

  • Webinar
  • August 2018
  • 180 Minutes
  • Global
Computer System Validation: Step-by-Step - Webinar (Recorded) - Product Thumbnail Image

Computer System Validation: Step-by-Step - Webinar (Recorded)

  • Webinar
  • August 2018
  • 90 Minutes
  • Global
Excel Spreadsheets for 21 CFR 11 Compliance - Webinar (Recorded) - Product Thumbnail Image

Excel Spreadsheets for 21 CFR 11 Compliance - Webinar (Recorded)

  • Webinar
  • August 2018
  • 90 Minutes
  • Global
From
Implementation and Management of GMP Data Integrity - Webinar (Recorded) - Product Thumbnail Image

Implementation and Management of GMP Data Integrity - Webinar (Recorded)

  • Webinar
  • July 2018
  • 60 Minutes
  • Global
From
Validation of Analytical Methods and Procedures - Webinar (Recorded) - Product Thumbnail Image

Validation of Analytical Methods and Procedures - Webinar (Recorded)

  • Webinar
  • June 2018
  • 75 Minutes
  • Global
From
Responding to FDA 483s and FDA Warning Letters - Webinar (Recorded) - Product Thumbnail Image

Responding to FDA 483s and FDA Warning Letters - Webinar (Recorded)

  • Webinar
  • June 2018
  • 90 Minutes
  • Global
From
Effective (FDA Accepted) Responses to FDA-483's and Warning Letters - Webinar (Recorded) - Product Thumbnail Image

Effective (FDA Accepted) Responses to FDA-483's and Warning Letters - Webinar (Recorded)

  • Webinar
  • March 2018
  • 90 Minutes
  • Global
Risk and FDA Inspections: Anticipation, Preparation, Reaction and Conclusion - Webinar - Product Thumbnail Image

Risk and FDA Inspections: Anticipation, Preparation, Reaction and Conclusion - Webinar

  • Webinar
  • 90 Minutes
  • Global
From
Implementation and Management of GMP Data Integrity - Webinar - Product Thumbnail Image

Implementation and Management of GMP Data Integrity - Webinar

  • Webinar
  • 60 Minutes
  • Global
Clinical Trials Audit Preparation. A Guide for Good Clinical Practice (GCP) Inspections. Edition No. 1 - Product Thumbnail Image

Clinical Trials Audit Preparation. A Guide for Good Clinical Practice (GCP) Inspections. Edition No. 1

  • Book
  • June 2010
  • 246 Pages
Manufacturing of Pharmaceutical Proteins. From Technology to Economy. Edition No. 3 - Product Thumbnail Image

Manufacturing of Pharmaceutical Proteins. From Technology to Economy. Edition No. 3

  • Book
  • January 2022
  • 496 Pages
Loading Indicator

The FDA Warning Letter market within the context of Pharmaceutical Manufacturing is a market that focuses on the enforcement of regulations and standards set by the U.S. Food and Drug Administration (FDA). Companies in this market are responsible for ensuring that their products meet the FDA's requirements for safety, efficacy, and quality. Companies must also comply with the FDA's Good Manufacturing Practices (GMPs) and other regulations. Companies that fail to meet these standards may receive a warning letter from the FDA, which can result in fines, product recalls, or other penalties. Companies in this market must also be aware of the latest developments in the industry, such as new regulations or changes to existing regulations. Some companies in the FDA Warning Letter market include Pfizer, Merck, Johnson & Johnson, Novartis, and GlaxoSmithKline. Show Less Read more